TapImmune: Undervalued Biotech Targeting Ovarian and Breast Cancer

Jun. 26, 2018
TapImmune Inc. (NASDAQ: TPIV) is developing immunotherapies for a variety of cancers designed to target both tumors and metastatic disease. The company's ...

 Read More

"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market